One of the major areas in which QPS serves the pharmaceutical industry is in Drug Metabolism and Pharmacokinetics (DMPK). Since its inception, QPS Pharmaceutical Services has maintained state-of-the-art bioanalytical facilities for top quality, accurate results. More recently, QPS has broadened its operations by building a DMPK department with the broad capabilities required for present-day drug discovery and development. Many members of the scientific staff in the DMPK group at QPS have very extensive experience in research and development at pharaceutical companies as well, and have shepherded projects from inception to market.

While some companies may use QPS Pharmaceutical Services for a particular study, others utilize QPS for all stages of DMPK work. In those cases, QPS scientists discuss and plan project status with client companies, and together decide on the sequence of DMPK studies that best move the project forward. And with extensive experience in taking projects through the various stages of development to drug approval, knowledgeable QPS scientists can be a valuable asset for companies that have not yet had this experience.

The goal of the QPS DMPK group is to fully serve its clients in fulfilling their DMPK needs, whatever they may be, and to be their preferred or sole DMPK resource.